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To generate CHOPWT10 cells, four Yamanaka reprogramming factors
(Oct3/4, Sox2, c-Myc, and Klf4) were delivered into mononuclear cells
through Sendai viral infection. The Sendai virus is non-integrating and
the absence of the vectors in the reprogrammed cells was conﬁrmed
by PCR analysis (Fig. 1A).B 5014, Philadelphia, PA 19104,
. This is an open access article underDNA ﬁngerprinting conﬁrmed the genetic relation of the derivative
line to the parental somatic line (Fig. 1B). The cells exhibited normal
karyotype (46, XY) upon G-band analysis (Fig. 1C).
Pluripotency was veriﬁed by gene expression of pluripotent stem
cell markers Oct4, Sox2, Nanog, Rex1, DMNT3B and ABCG2 by qPCR
(Fig. 1D). In addition, pluripotent surfacemarker expression at single
cell resolution of SSEA3, SSEA4, Tra-1-60, and Tra-1-81 were con-
ﬁrmed by ﬂow cytometry (Fig. 1E). Differentiation capacity into
three germ layers was conﬁrmed by PluriTest™ and quantitative
PCR (Fig. 2).
Materials and methods
Blood sample collection and processing
Blood samples were collected from a healthy adult male into BD
Vacutainer cell preparation tubes. The PBMCswere isolated by centrifu-
gation at 1800 rcf for 30 min, after which mononuclear cells were
transferred to a fresh tube, washed with PBS, and pelleted at 300 rcf
for 10 min. Pellets were resuspended in freezing media (90% FBS, 10%
DMSO) and stored in liquid nitrogen. Blood collection was approved
by the CHOP Institutional Review Board committee with written
informed consent.
iPS cell reprogramming
The PBMCs were expanded and reprogrammed as previously
described (Yang et al., 2012). Brieﬂy, PBMCs were expanded in
QBSF-60 medium containing EPO (2 U/mL), IGF-1 (40 ng/mL), SCF
(50 ng/mL), IL-3 (10 ng/mL), dexamethasone (1.5 μM), ascorbicthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Generation and characterization of CHOPWT10. (A) PCR analysis of reprogramming genes after 20 passages of CHOPWT10 using GAPDH as a loading control. Cells harvested
immediately post-Sendai infection were used as a positive control. (B) CHOPWT10 iPS cells compared to parental cells by DNA ﬁngerprinting. (C) Karyotype analysis of CHOPWT10.
(D) Quantitative PCR of relative gene expression of pluripotency genes compared to embryonic stem cells (H9) and a control iPS cell line (CHOPWT6). (E) Flow cytometry proﬁles of
surface markers on undifferentiated cells: SSEA3, SSEA4, TRA-1-60, and TRA-1-81.
339J.A. Maguire et al. / Stem Cell Research 16 (2016) 338–341acid (50 ng/mL), glutamine (1%), and penicillin/streptomycin (1%)
for 7 days. Cells were transduced with Sendai virus expressing
human Oct3/4, Sox2, Klf4, and c-Myc. (Life Technologies) (moiaccording to manufacturer's instructions). Transduced cells were
plated on culture dishes containing irradiated mouse embryonic ﬁ-
broblasts (MEFs), and maintained in human embryonic stem
340 J.A. Maguire et al. / Stem Cell Research 16 (2016) 338–341cell media (HES) containing 5 ng/mL of bFGF. The medium was
replenished every 2–3 days for 3 weeks. Cells were maintained
in these conditions until uniform colonies were generated, and
iPS cell colonies were mechanically isolated and expanded on
MEFs.
DNA ﬁngerprinting
Conﬁrmation of the genetic integrity of the iPS cell line to the paren-
tal line was established by DNA ﬁngerprinting. PCR ampliﬁcation was
performed on genomic DNA isolated from parental and iPS cells with
reference primer sets (Ban et al., 2011; Park et al., 2011; Dirks et al.,
1999). Products were separated on a 3.0% agarose gel and visualized
with ethidium bromide.
Karyotype analysis
Chromosomal G-band analyses were performed by Cell Line
Genetics (Madison, WI).Fig. 2. Pluripotency potential of CHOPWT10. (A) Fold change in expression of pluripotency gene
results using embryonic stem cells (H9) as a control.RT-PCR and quantitative PCR
RNA was isolated from the CHOPWT10 iPS cells using the RNeasy
micro kit (Qiagen) according to the manufacturer's protocol. Reverse
transcription was performed using random hexamers with Superscript
III Reverse Transcriptase (Life Technologies) and 500 ng total RNA.
cDNAwas used as a template for PCR ampliﬁcation of the viral backbone
and exogenous reprogramming factors (SeV, Klf4, Oct3/4, Sox2, and
c-Myc). Primer sequences were provided by the company (Life Tech-
nologies). PCR products were separated on a 2.0% agarose gel and
visualized with ethidium bromide. RT-qPCR was performed on a
LightCycler-480II (Roche, IN). All experiments were performed in
triplicate using SYBR-Green qPCR supermix (Roche) according to
the manufacturers instructions. Primers for all endogenous genes
were prepared as previously described (Mills et al., 2013). Human
genomic DNA (gDNA), diluted in 10-fold increments from 1 to
100 ng/μL, was used for the qPCR standard curve to determine PCR
efﬁciency and relative gene expression compared to the housekeep-
ing gene TBP (TATA Binding Box Protein).s and genes speciﬁc to each germ layer compared to undifferentiated cells. (B) PluriTest™
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Expression of pluripotency markers were evaluated by ﬂow
cytometry using the following antibodies: Alexa-Fluor®-647 α-human
SSEA4 (1:400) and Tra-1-681 (1:200); Alexa-Fluor®-488 SSEA3
(1:200) and Tra-1-60 (1:200) (BioLegend). Accutase-dissociated single
cells were analyzed using a FACSCanto ﬂow cytometer (BD Biosciences)
and the FlowJo software program (Tree Star, CA).Pluripotency potential
PluriTest™ was performed as previously described (Muller et al.,
2011) using Illumina HT12 array and the PluriTest Software (www.
pluritest.org) by the Coriell Institute for Medical Research. Pluripotent
cells have a Pluripotency Score greater than 20 and Novelty Score less
than 1.62. Embryonic stem cells (H9) were used as a control and
each sample was run as a biological replicate. To measure the capacity
to form three germ layers, CHOPWT10 cells were differentiated using
embryoid body formation. Gene expression was measured by quantita-
tive RT-PCR using the endogenous housekeeping gene, GAPDH.
Pluripotency was conﬁrmed by two-fold or higher expression of atleast one gene speciﬁc to each germ layer compared to undifferentiated
cells.
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